This table shows Vertex Pharmaceuticals Incorporated's quarterly financial data. All values are USD millions unless otherwise specified.
| METRIC |
2025
2025-09-30
|
2025
2025-06-30
|
2025
2025-03-31
|
2024
2024-12-31
|
|
|---|---|---|---|---|---|
| Revenue | 3,076 | 2,965 | 2,770 | 2,912 | |
| Cost of Revenue | 415 | 408 | 363 | 423 | |
| Gross Profit | 2,662 | 2,557 | 2,407 | 2,489 | |
| Operating Expenses | 1,475 | 1,406 | 1,777 | 1,463 | |
| Operating Income | 1,186 | 1,151 | 630 | 1,026 | |
| Interest Expense | 3 | 4 | 3 | 3 | |
| Income Tax Expense | 216 | 250 | 84 | 224 | |
| Net Income | 1,083 | 1,033 | 646 | 913 | |
| EBITDA | 1,356 | 1,338 | 782 | 1,184 | |
| Basic EPS | $4.24 | $4.02 | $2.52 | $3.55 | |
| Diluted EPS | $4.20 | $3.99 | $2.49 | $3.50 | |
| METRIC |
2025
2025-09-30
|
2025
2025-06-30
|
2025
2025-03-31
|
2024
2024-12-31
|
|
|---|---|---|---|---|---|
| Operating Activities | |||||
| Cash from Operations | 1,241 | 1,073 | 819 | 585 | |
| Investing Activities | |||||
| Capital Expenditures | -102 | -146 | -41 | -93 | |
| Cash from Investing | -117 | -485 | -56 | -822 | |
| Financing Activities | |||||
| Dividends Paid | — | — | — | — | |
| Stock Repurchased | 1,094 | -398 | -697 | -425 | |
| Cash from Financing | -1,155 | -349 | -680 | -391 | |
| Free Cash Flow | 1,140 | 927 | 778 | 492 | |
| METRIC |
2025
2025-09-30
|
2025
2025-06-30
|
2025
2025-03-31
|
2024
2024-12-31
|
|
|---|---|---|---|---|---|
| Assets | |||||
| Cash & Equivalents | 4,940 | 4,972 | 4,675 | 4,570 | |
| Short-term Investments | 1,347 | 1,411 | 1,527 | 1,546 | |
| Accounts Receivable | 1,946 | 1,894 | 1,805 | 1,609 | |
| Inventory | 1,627 | 1,499 | 1,360 | 1,205 | |
| Total Current Assets | 10,570 | 10,428 | 10,009 | 9,596 | |
| Total Assets | 24,862 | 24,037 | 22,881 | 22,533 | |
| Liabilities | |||||
| Accounts Payable | 4,034 | 442 | 445 | 413 | |
| Short-term Debt | 0 | 0 | 0 | 0 | |
| Total Current Liabilities | 4,475 | 4,138 | 3,783 | 3,565 | |
| Long-term Debt | 0 | 0 | 0 | 0 | |
| Total Liabilities | 7,544 | 6,861 | 6,384 | 6,124 | |
| Shareholders' Equity | |||||
| Total Stockholders' Equity | 17,319 | 17,175 | 16,496 | 16,410 | |
| Total Debt | 1,835 | 1,527 | 1,649 | 1,750 | |